Abstract Details

Title The Cross-Reactivity of the Neutralizing Antibodies (NAbs) to the Different Interferons (IFN) Used To Treat Multiple Sclerosis Is Very Far from Complete and This Has Major Clinical Relevance for Defining Positivity and High Titers

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 079

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Joel J. Oger, MD, FRCPC, FAAN	No disclosure on file
Raquel Gardner, MD (Sheba Medical Center)	Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Regina Lam	No disclosure on file
Ebrima Gibbs, Bsc, BMLSc, MSc (University of British Columbia)	Dr. Gibbs has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Promis Neurosciences.
Abubaker Almadani, MD (Dubai Health Authority)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��